General Information
Ionis Hypertriglyceridemia CS8
“A Randomized, Double-blind, Placebo-Controlled, Phase 2b Study of ISIS 678354 in Patients with Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease (Established or at Increased Risk for), and/or with Severe Hypertriglyceridemia”
| Protocol | ISIS 678354-CS8 |
|---|---|
| Identifier | |
| UID | 2228ef45-4fd6-4da2-a742-a1e5c2271b89 |
| Status | Done - Archived |
| Phase | 2b |
| Category | Hypertriglyceridemia / Adult |
| Launch Year | 2022 |
| NCT Number | - |
| Created | 2022-03-23 13:13 |
| Last Updated | 2024-04-02 20:05 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | 2022-08-11 | No |
| Enrollment Open | 2022-07-05 | No |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2022-05-12 | No |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2024-03-26 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Mohseni, Rizwana | RMohseni | No |
| Recruiter | Gomez, Kathie | KGomez | No |
| Coordinator | Navarrete, Connie | CNavarrete | No |
| Regulatory | Ramirez, Claudia | CRamirez | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Ionis Pharmaceuticals |
|---|---|
| Division | Ionis Pharmaceuticals |
| Team | Ionis Pharmaceuticals |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | Medpace, Inc. |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
